ClinicalTrials.gov record
Recruiting Phase 3 Interventional

AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight

ClinicalTrials.gov ID: NCT07533175

Public ClinicalTrials.gov record NCT07533175. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 6, 2026, 8:13 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Efficacy and Safety of NNC0487-0111 s.c. Once-weekly in Participants With Overweight or Obesity, and Type 2 Diabetes (AMAZE 2)

Study identification

NCT ID
NCT07533175
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Novo Nordisk A/S
Industry
Enrollment
630 participants

Conditions and interventions

Interventions

  • NNC0487-0111 Drug
  • Placebo (matched to NNC0487-0111) Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 12, 2026
Primary completion
May 14, 2028
Completion
Aug 6, 2028
Last update posted
Apr 26, 2026

2026 – 2028

United States locations

U.S. sites
15
U.S. states
9
U.S. cities
15
Facility City State ZIP Site status
Univ of Alabama Birmingham Birmingham Alabama 35294 Recruiting
Headlands Research California, LLC Escondido California 92025 Recruiting
Torrance Clinical Research Institute, Inc. Lomita California 90717 Recruiting
Diablo Clinical Research, Inc. Walnut Creek California 94598 Recruiting
Northeast Research Institute Fleming Island Florida 32003 Recruiting
Jacksonville Ctr Clin Res Jacksonville Florida 32216 Recruiting
Florida Institute for Clinical Research, LLC Orlando Florida 32825 Recruiting
Oviedo Medical Research, LLC Oviedo Florida 32765 Recruiting
International Diabetes Center Minneapolis Minnesota 55416 Recruiting
Southgate Medical Group, LLP West Seneca New York 14224 Recruiting
Spartanburg Medical Research Spartanburg South Carolina 29303 Recruiting
M3 Wake Research Chattanooga Chattanooga Tennessee 37421 Recruiting
UT Southwestern Medical Center - Lingvay Dallas Texas 75390 Recruiting
PlanIt Research, PLLC Houston Texas 77079 Recruiting
National Clin Res Inc. Richmond Virginia 23294 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 58 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT07533175, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 26, 2026 · Synced May 6, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT07533175 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →